Wilhelmus Groenhuysen

2016

In 2016, Wilhelmus Groenhuysen earned a total compensation of $6.3M as Chief Financial Officer at NovoCure, a 90% increase compared to previous year.

Compensation breakdown

Option Awards$5,630,025
Salary$600,600
Other$28,470
Total$6,259,095

Groenhuysen received $5.6M in option awards, accounting for 90% of the total pay in 2016.

Groenhuysen also received $600.6K in salary and $28.5K in other compensation.

Rankings

In 2016, Wilhelmus Groenhuysen's compensation ranked 1,115th out of 14,075 executives tracked by ExecPay. In other words, Groenhuysen earned more than 92.1% of executives.

ClassificationRankingPercentile
All
1,115
out of 14,075
92nd
Division
Manufacturing
376
out of 5,489
93rd
Major group
Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks
45
out of 827
95th
Industry group
Surgical, Medical, And Dental Instruments And Supplies
20
out of 510
96th
Industry
Surgical and Medical Instruments and Apparatus
10
out of 313
97th
Source: SEC filing on March 28, 2017.

Groenhuysen's colleagues

We found three more compensation records of executives who worked with Wilhelmus Groenhuysen at NovoCure in 2016.

2016

Asaf Danziger

NovoCure

Chief Executive Officer

2016

Eilon Kirson

NovoCure

Chief Scientific Officer

2016

Michael Ambrogi

NovoCure

Chief Operating Officer

News

In-depth

You may also like